In vitro activity of BL-S217, a new cephalosporin antibiotic.
D000081:Acetamides / Q000494:pharmacology; D002506:Cephalexin / Q000494:pharmacology; D002509:Cephaloridine / Q000494:pharmacology; D002511:Cephalosporins / Q000494:pharmacology*; D002512:Cephalothin / Q000494:pharmacology; D004755:Enterobacteriaceae / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D007709:Klebsiella / Q000187:drug effects; D011513:Proteus mirabilis / Q000187:drug effects; D011726:Pyridinium Compounds / Q000494:pharmacology; D012706:Serratia marcescens / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000187:drug effects; D013297:Streptococcus pyogenes / Q000187:drug effects
D000081:Acetamides; D002511:Cephalosporins; D011726:Pyridinium Compounds; D002509:Cephaloridine; D002506:Cephalexin; D002512:Cephalothin